Skip to main content
Premium Trial:

Request an Annual Quote

Eurobio Gets CE Mark for Multiplexed SARS-CoV-2, Influenza A/B, RSV Test

NEW YORK – Eurobio Scientific said on Tuesday that it has received CE marking for its EBX 042 FluCoSyn test, which can identify viruses for the main flu-like symptoms.

The Paris-based firm said the RT-PCR assay can be used to test for SARS-CoV-2, influenza A and B, and respiratory syncytial virus from one patient sample. More specifically, the multiplex kit has five targets, the R and N genes for SARS-CoV-2; one common target for influenza A and B; one target for RSV; and one target for the control integrated into each test to validate the correct functioning of the reaction.

Eurobio said the test can be used directly on any open instrument, including portable systems, and it allows for detection of pathogens in about 75 minutes.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.